ATS Breathe Easy

GuestBhakti Patel MDUniversity of Chicago, Chicago ILPulmonary and Critical Care Medicine HostMatt Stutz MDCook County Health and Hospital System, Chicago ILPulmonary and Critical Care Medicine

Show Notes If you enjoyed this content, please follow or subscribe and leave us a review!  Access the ATS Reading List. Recommended Reading Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347:1143-50. Meyer G, Vicaut E, Danays T, et al. PEITHO investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370:1402-11.Supplement to: Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402-11. DOI: 10.1056/NEJMoa1302097Rali P, Criner GJ. Submassive Pulmonary Embolism. Am J Respir Crit Care Med 2018; 198(5):588-98. Chaudhury P, Gadre SK, Schneider E, et al. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes. Am J Cardiol 2019; 124:1465-69. Konstantinides S, Vicaut E, Danays T, et al. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. J Am Coll Cardiol. 2017 Mar, 69 (12) 1536–1544.

Show NotesIf you enjoyed this content, please follow or subscribe and leave us a review!  Access the ATS Reading List. Recommended ReadingGuntupalli, et al. 2015. Critical Illness in Pregnancy. Part I.Guntupalli, et al. 2015. Critical Illness in Pregnancy. Part II. Hunt, 2015. Bleeding and Coagulopathies in Critical Care. Arnold, et al. 2017. Thrombotic Microangiopathies: A General Approach to Diagnosis and Management.Levi and Scully. 2018. How I Treat Disseminated Intravascular Coagulation. Tolcher et al. 2020. Prone Positioning for Pregnant Women With Hypoxemia Due to Coronavirus Disease 2019 (COVID-19)

Speech Pathology AustraliaAmerican Speech-Language-Hearing Association (ASHA)European Speech and Language Therapy AssociationGuestA/Prof Anne VertiganUniversity of Newcastle, and Treatable Traits Centre of Research Excellence, Australia HostDr Hayley LewthwaiteUniversity of Newcastle, and Treatable Traits Centre of Research Excellence, Australia 

Show NotesIf you enjoyed this content, please follow or subscribe and leave us a review! Access the ATS Reading List.Recommended ReadingPulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369(9):809-818. Supplement to: Pulido T et al. 2013. Galiè N, Barberà JA, Frost AE, et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015;373(9):834-844. doi:10.1056/NEJMoa1413687Supplement to: Galiè et al. 2015. Simonneau G, Channick RN, Delcroix M, et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J. 2015;46(6):1711-1720. doi:10.1183/13993003.00364-2015

Guests Blanca Himes PhDUniversity of PennsylvaniaCraig Hersh, MD, MPHBrigham and Women's Hospital and Harvard Medical SchoolHostsMatthew Moll, MD, MPHBrigham and Women's Hospital and Harvard Medical School Victor Ortega, MD, PhDMayo Clinic

Show Notes If you enjoyed this content, please follow or subscribe and leave us a review! Access the ATS Reading List.

HostAlex Jenkins, PhDMcGill University, Canada ATS Evidence Synthesis Methodology Working Group MemberGuestArwel Jones, PhDMonash University, AustraliaTSANZ Evidence-Based Medicine & Practice Special Interest Group & ERS Clinical Practice Guideline Methodology Network Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training 

HostRick Koubek, MDPulmonary and Critical Care Medicine, Spectrum Health, Grand Rapids, MIClinical Assistant Professor of Medicine, Michigan State University  GuestsDr. Molly Hayes, MDAssistant Professor of Medicine at Harvard Medical School, Director of the Medical Intensive Care Units, Beth Israel Deaconess Medical CenterDirector for External Education at the Carl J. Shapiro Institute for Education and ResearchVice-chair of the ATS Education Committee and the Chair of the Core CurriculumMember, Editorial Board, ATS Scholar  Dr. Hank Fessler, MDProfessor of Medicine and Public Health at Johns Hopkins University School of MedicineDirector for Education in the Division of Pulmonary and Critical CareAssociate Editor, ATS Scholar Show NotesHow We Review a Medical Education Research ManuscriptQuestions or comments? Contact us

GuestDr. Edmund MoonMedical Director Cell/Gene Therapy Program GlaxoSmithKlineFormerly Associate Professor of Medicine at the Hospital of the University of PennsylvaniaSection of Interventional Pulmonology HostDr. Mark Weir M.B Ch.B Assistant Professor Thoracic Medicine at Lewis Katz School of MedicineTemple University